AI-generated content for informational purposes only. Not financial advice. Always do your own research.

About

Curaleaf Holdings (OTC: CURLF) is one of the largest multi-state cannabis operators in the United States, operating cultivation, processing, and retail dispensary operations across numerous states with a significant international presence in Europe through its acquisition of EMMAC Life Sciences. The company has built a vertically integrated platform with a portfolio of owned brands including Select, Grassroots, and Find, generating among the highest revenues of any U.S. cannabis company. As an investment, Curaleaf offers direct exposure to the U.S. cannabis market with operational scale and geographic diversification, though its OTC listing, ongoing industry-wide profitability challenges, and the uncertain timeline for federal reform remain important considerations for investors.

Cannabis Stocks

Curaleaf is a leading cannabis stock representing one of the largest plant-touching marijuana operators in the United States, with a multi-state dispensary and cultivation footprint that positions it to benefit significantly from any federal legalization or rescheduling of cannabis.

Key Financials CURA

Price $3.31
Change (1D) +2.16%
Change (30D) -7.54%
Change (60D) +21.25%
Change (90D) -24.43%
Change (180D) +171.31%
Change (1Y) +57.62%
P/E Ratio -12.26
EPS (TTM) $-0.27
52-Week Range $0.99 โ€” $6.98
50-Day MA $3.68
Volume 355.4K

Data updated Feb 15 ยท Source: Twelve Data

4.2 2 reviews

AI Reviews

๐Ÿค–
4.2 /5

Curaleaf Holdings is the largest multi-state cannabis operator in the U.S. by revenue, with operations spanning cultivation, processing, and retail across numerous states and international markets. The company's scale provides meaningful competitive advantages in procurement, branding, and regulatory navigation.

The bull case centers on Curaleaf's market leadership position and potential federal rescheduling or legalization catalysts, evidenced by the 171% gain over six months as sentiment improved. Its extensive retail footprint and brand portfolio (Select, Grassroots) create durable competitive moats in a fragmented industry.

However, the bear case is significant. The negative P/E ratio of -12.26 and EPS of -$0.27 reflect ongoing profitability challenges common across cannabis MSOs. The stock trades well below its 52-week high of $6.98, and the 24% decline over 90 days suggests fading momentum as rescheduling timelines remain uncertain. Heavy debt loads and 280E tax burdens continue to pressure cash flows.

Curaleaf remains a top-tier cannabis play for investors with high risk tolerance, but profitability must materialize to justify current valuations. Regulatory catalysts remain the key swing factor.

Category Ratings

Cannabis Stocks
4.2
Feb 15, 2026
AI-Generated Review Generated via Anthropic API. This is an automated evaluation, not a consumer review. Learn more
๐Ÿค–
4.2 /5
Curaleaf Holdings maintains its status as a top-tier U.S. Multi-State Operator (MSO), distinguished by its massive geographic footprint and strategic expansion into the European market. For investors, the primary thesis rests on Curaleaf's scale advantage and its ability to capitalize on potential regulatory shifts, such as federal rescheduling. However, the company's financials reflect the broader challenges of the cannabis industry; with a trailing EPS of -$0.27 and a negative P/E ratio, profitability remains hindered by tax burdens and capital-intensive growth. The stock currently trades at $3.24, which is below its 50-day moving average of $3.68, indicating recent bearish momentum despite trading significantly above its 52-week low of $0.99. While Curaleaf represents one of the more stable vehicles for exposure to the cannabis sector, it remains a speculative investment requiring patience for regulatory clarity and improved cash flow generation.

Category Ratings

Cannabis Stocks
4.2
Feb 11, 2026
AI-Generated Review Generated via Google API. This is an automated evaluation, not a consumer review. Learn more
Curaleaf Holdings Screenshot

Added: Feb 10, 2026

curaleaf.com